These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6199959)

  • 1. [Investigation of interferon system in sarcoidosis].
    Ohno S; Kotake S; Matsuda H; Fujii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1983; 87(11):1050-6. PubMed ID: 6199959
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of acid-labile interferon in the serum of sarcoidosis patients.
    Rottoli L; Rottoli P; Muscettola M; Grasso G; Bocci V
    Acta Virol; 1985 Jan; 29(1):91. PubMed ID: 2581431
    [No Abstract]   [Full Text] [Related]  

  • 3. Uveitis and pediatric sarcoidosis: does IgG really matter?
    Gonzalez-Granado LI
    Arch Neurol; 2011 Jan; 68(1):136; author reply 136-7. PubMed ID: 21220689
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of corticosteroids on interferon system in Vogt-Koyanagi-Harada's disease].
    Kotake S; Ohno S; Fujii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1984 Jul; 88(7):1021-6. PubMed ID: 6208768
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive value of serum markers for pulmonary involvement in ocular sarcoidosis.
    Grajewski RS; Adler W; Frank KF; Arfaoui M; Schlereth SL; Kirchhof B; Cursiefen C; Heindl LM
    Acta Ophthalmol; 2014 May; 92(3):e250-1. PubMed ID: 23910667
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum interferon in acute nongranulomatous anterior uveitis.
    Epstein DL
    Arch Ophthalmol; 1970 Aug; 84(2):235. PubMed ID: 5449639
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon status in atopic dermatitis].
    Iashaeva IG; Samsonov VA; Malinovskaia VV; Dzhumigo PA
    Sov Med; 1990; (6):92-4. PubMed ID: 1697700
    [No Abstract]   [Full Text] [Related]  

  • 8. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
    Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon secretion in patients with chronic urticaria and Quincke's edema].
    Belonogova TS; Ol'shanskiĭ IaO; Ershov FI; Ol'shanskaia NV; Lavrukhina LA
    Sov Med; 1985; (7):27-30. PubMed ID: 2416063
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferon production and lymphoproliferation in whole blood of schizophrenia patients].
    Schindler L; Beck J; Moises HW; Kirchner H
    Immun Infekt; 1985 Apr; 13(2):87-8. PubMed ID: 2581886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoidal tattoo granuloma.
    Anolik R; Mandal R; Franks AG
    Dermatol Online J; 2010 Nov; 16(11):19. PubMed ID: 21163170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma. A preliminary report.
    Ikossi-O'Connor MG; Ambrus JL; West T; Lillie MA; Milgrom H; Chadha KC
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):271-7. PubMed ID: 6207572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease.
    Charlier C; Nunes H; Trinchet JC; Roullet E; Mouthon L; Beaugrand M; Valeyre D
    Eur Respir J; 2005 Mar; 25(3):570-3. PubMed ID: 15738304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
    Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
    J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of interferon in the sera and cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease (author's transl)].
    Kato F; Ohno S; Matsuda H; Fujii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1981 Mar; 85(3):217-21. PubMed ID: 6168187
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
    Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous sarcoidosis in a woman with chronic hepatitis C and interferon therapy: a case report.
    Song K; Das K
    Acta Cytol; 2010; 54(5 Suppl):863-6. PubMed ID: 21053557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The interferon status in diabetes mellitus].
    Sidorova LD; Bondar' IA; Iavorskaia VE; Evstropov AN
    Ter Arkh; 1993; 65(10):20-3. PubMed ID: 7507602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey.
    Sungur G; Hazirolan D; Bilgin G
    Ocul Immunol Inflamm; 2013 Dec; 21(6):455-61. PubMed ID: 23909887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.